Immunodiagnostic Systems Hldgs (LON:IDH), the company that produces diagnostic testing kits for the clinical and research markets, this morning reported that year-on-year sales in the first six months of the year were up 34% at £22.6m and 11% ahead of the second half of 2009 on a like for like basis.
In a trading update ahead of its interim results to September 30, which are due to be published on November 30, IDH said it had made continued progress in placing instruments into reagent rental accounts as well as outright unit sales. At the end of September the group had sold or placed 140 iSYS machines since launch in February 2009, almost doubling the number of machines in the market at the previous financial year in March. IDH added that overall trading remained in line with management expectations and it was confident going forward that it would continue to execute its plans for the current year.
Shares in IDH reached a 12 month high of 920.5p yesterday. Earlier this summer outgoing chief executive Roger Duggan spoke to Stockopedia about the “astonishing” trajectory of the company’s stock this year.
Filed Under: Medical Equipment,